Neutralizing epitopes of influenza virus hemagglutinin: Target for the development of a universal vaccine against H5N1 lineages

Journal of Virology

Volumn 84, Issue 22, 2010, Pages 11822-11830

  Prabakaran, Mookkan ^a   He, Fang ^a   Meng, Tao ^a   Madhan, Selvaraj ^a   Yunrui, Tan ^a   Jia, Qiang ^a   Kwang, Jimmy ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS A H5N1 VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CLADISTICS; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; EPITOPE MAPPING; FEMALE; HEMAGGLUTINATION INHIBITION; HISTOPATHOLOGY; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS MUTATION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; CELL LINE; EPITOPES; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS;

MUS; ORTHOMYXOVIRIDAE;

EID: 78049495617     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00891-10     Document Type: Article

References (36)

1. Ayora-Talavera, G., H. Shelton, M. A. Scull, J. Ren, I. M. Jones, R. J. Pickles, and W. S. Barclay. 2009. Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium. PLoS One 4:e7836.
2. Chen, G. L., and K. Subbarao. 2009. Attacking the flu: neutralizing antibodies may lead to universal vaccine. Nat. Med. 15:1251-1252.
3. Cieplik, M., H. D. Klenk, and W. Garten. 1998. Identification and characterization of Spodoptera frugiperda furin: a thermostable subtilisin-like endopeptidase. Biol. Chem. 379:1433-1440.
4. Copeland, C. S., R. W. Doms, E. M. Bolzau, R. G. Webster, and A. Helenius. 1986. Assembly of influenza hemagglutinin trimers and its role in intracellular transport. J. Cell Biol. 103:1179-1191.
5. de Filette, M., W. M. Jou, A. Birkett, K. Lyons, B. Schultz, A. Tonkyro, S. Resch, and W. Fiers. 2005. Universal influenza A vaccine: optimization of M2-based constructs. Virology 337:149-161.
6. Fan, J., X. Liang, M. S. Horton, H. S. Perry, M. P. Citron, G. J. Heidecker, T. M. Fu, J. Joyce, C. T. Przysiecki, P. M. Keller, V. M. Garsky, R. Ionescu, Y. Rippeon, L. Shi, M. A. Chasain, J. H. Condra, M. E. Davies, J. Liao, E. A. Emini, and J. W. Shiver. 2004. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 22:2993-3003.
7. Frace, A. M., A. I. Klimov, T. Rowe, R. A. Black, and J. M. Katz. 1999. Modified M2 proteins produce heterotypic immunity against influenza A virus. Vaccine 17:2237-2244.
8. Govorkova, E. A., R. J. Webby, J. Humberd, J. P. Seiler, and R. G. Webster. 2006. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J. Infect. Dis. 194:159-167.
9. Kaverin, N. V., I. A. Rudneva, N. A. Ilyushina, N. L. Varich, A. S. Lipatov, Y. A. Smirnov, E. A. Govorkova, A. K. Gitelman, D. K. Lvov, and R. G. Webster. 2002. Structure of antigenic sites on the hemagglutinin molecule of H5 influenza virus and phenotypic variation of escape mutants. J. Gen. Virol. 83:2497-2505.
10. Kaverin, N. V., I. A. Rudneva, E. A. Govorkova, T. A. Timofeeva, A. A. Shilov, K. S. Kochergin-Nikitsky, P. S. Krylov, and R. G. Webster. 2007. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J. Virol. 81:12911-12917.
11. King, D. J. 1991. Evaluation of different methods of inactivation of Newcastle disease virus and avian influenza virus in egg fluids and serum. Avian Dis. 35:505-514.
12. Kuroda, K., C. Hauser, R. Rott, H. D. Klenk, and W. Doerfler. 1986. Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector. EMBO J. 5:1359-1365.
13. Lam, T. T., C. C. Hon, O. G. Pybus, S. L. K. Pond, R. T. Wong, C. W. Yip, F. Zeng, and F. C. Leung. 2008. Evolutionary and transmission dynamics of reassortant H5N1 influenza virus in Indonesia. PLoS Pathog. 4:e1000130.
14. Liu, W., H. Li, and Y-H. Chen. 2003. N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication. FEMS Immunol. Med. Microbiol. 35:141-146.
15. Manzoli, L., F. Schioppa, A. Boccia, and P. Villari. 2007. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr. Infect. Dis. J. 26:97-106.
16. Marasco, W. A., and J. Sui. 2007. The growth and potential of human antiviral monoclonal antibody therapeutics. Nat. Biotechnol. 25:1421-1434.
17. National Institutes of Health and Centers for Disease Control and Prevention. 1999. Biosafety in microbiological and biomedical laboratories, 4th ed. U.S. Department of Health and Human Services, Washington, DC.
18. O'Reilly, D. R., L. K. Miller, and V. A. Luckow. 1992. Baculovirus expression vectors: a laboratory manual. W. H. Freeman and Company, New York, NY.
19. Park, A. W., J. M. Daly, N. S. Lewis, D. J. Smith, J. L. Wood, and B. T. Grenfell. 2009. Quantifying the impact of immune escape on transmission dynamics of influenza. Science 326:726-728.
20. Plotkin, J. B., J. Dushoff, and S. A. Levin. 2002. Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc. Natl. Acad. Sci. U. S. A. 99:6263-6268.
21. Prabakaran, M., S. Velumani, F. He, A. K. Karuppannan, G. Y. Geng, L. K. Yin, and J. Kwang. 2008. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Virology 380:412-420.
22. Prabakaran, M., H. T. Ho, N. Prabhu, S. Velumani, M. Szyporta, F. He, K. P. Chan, L. M. Chen, Y. Matsuoka, R. O. Donis, and J. Kwang. 2009. Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS One 4:e4566.
23. Prabakaran, M., N. Prabhu, F. He, Q. Hongliang, H. T. Ho, J. Qiang, T. Meng, M. Goutama, and J. Kwang. 2009. Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants. PLoS One 4:e5672.
24. Prabakaran, M., S. Madhan, N. Prabhu, J. Qiang, and J. Kwang. 2010. Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection. J. Virol. 84:3201-3209.
25. Recker, M., O. G. Pybus, S. Nee, and S. Gupta. 2007. The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types. Proc. Natl. Acad. Sci. U. S. A. 104:7711-7716.
26. Rowe, T., R. A. Abernathy, J. Hu-Primmer, W. W. Thompson, X. Lu, W. Lim, K. Fukuda, N. J. Cox, and J. M. Katz. 1999. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol. 37:937-943.
27. Rueda, P., J. Fominaya, J. P. M. Langeveld, C. Bruschke, C. Vela, and J. I. Casal. 2000. Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles. Vaccine 19:726-734.
28. Russell, C. A., T. C. Jones, I. G. Barr, N. J. Cox, R. J. Garten, V. Gregory, I. D. Gust, A. W. Hampson, A. J. Hay, A. C. Hurt, J. C. de Jong, A. Kelso, A. I. Klimov, T. Kageyama, N. Komadina, A. S. Lapedes, Y. P. Lin, A. Mosterin, M. Obuchi, T. Odagiri, A. D. Osterhaus, G. F. Rimmelzwaan, M. W. Shaw, E. Skepner, K. Stohr, M. Tashiro, R. A. Fouchier, and D. J. Smith. 2008. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 12(Suppl. 4):D31-D34.
29. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569.
30. Stevens, J., O. Blixt, T. M. Tumpey, J. K. Taubenberger, J. C. Paulson, and I. A. Wilson. 2006. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404-410.
31. Wang, T. T., and P. Palese. 2009. Universal epitopes of influenza virus hemagglutinins? Nat. Struct. Mol. Biol. 16:233-234.
32. Webster, R. G., Y. Kawaoka, J. Taylor, R. Weinberg, and E. Paoletti. 1991. Efficacy of nucleoprotein and hemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9:303-308.
33. WHO. 2005. Evolution of H5N1 avian influenza viruses in Asia. Emerg. Infect. Dis. 11:1515-1521.
34. Wilson, I. A., and N. J. Cox. 1990. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 8:737-771.
35. Wu, F., J. H. Huang, X. Y. Yuan, W. S. Huang, and Y. H. Chen. 2007. Characterization of immunity induced by M2e of influenza virus. Vaccine 25:8868-8873.
36. Yokoyama, W. M. 2001. Production of monoclonal antibody, p. 2.5.1-2.5.17. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology. John Wiley & Sons, Inc., Newcastle, United Kingdom.